4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-029072
Chief Executive Officer sold 20,350 shares at $0.68 ($13,838)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-08-16 | Sale | −20,350 | $0.68 | $13,838 | 3,860,438 | D |
| Open-market sales · 20,350 sh · avg $0.68 · $13,838 | |||||||
Loading xslF345X03/doc4.xml…